Long-term sacubitril/valsartan therapy improved central pulse wave parameters in patients with stable heart failure with reduced ejection fraction

被引：0
|
作者：
Kobalava, Z. [1 ]
Villevalde, S. [1 ]
Lukina, O. [1 ]
Babaeva, L. [1 ]
Meray, I. [1 ]
机构：
[1] RUDN Univ, Moscow, Russia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P915
引用
收藏
页码：208 / 209
页数：2
相关论文
共 50 条
  • [31] Use and Benefit of Sacubitril/Valsartan in Elderly Patients with Heart Failure with Reduced Ejection Fraction
    Roca, Luis Nieto
    Garcia, Marcelino Cortes
    German, Jorge Balaguer
    Becerra, Antonio Jose Bollas
    Otero, Jose Maria Romero
    Chapel, Jose Antonio Esteban
    Lopez, Carlos Rodriguez
    Lazaro, Ana Maria Pello
    Urquia, Mikel Taibo
    Tunon, Jose
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [32] The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension
    Takigami, Yu
    Ishii, Shunsuke
    Eda, Yuko
    Yazaki, Mayu
    Fujita, Teppei
    Iida, Yuichiro
    Ikeda, Yuki
    Nabeta, Takeru
    Oikawa, Jun
    Koitabashi, Toshimi
    Ako, Junya
    HEART AND VESSELS, 2023, 38 (11) : 1337 - 1343
  • [33] Real world experience of sacubitril and valsartan in patients with heart failure with reduced ejection fraction
    Ganesananthan, S.
    Shah, N.
    Shah, P.
    Phillips, J.
    Elsayed, H.
    Yousef, Z.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 222 - 222
  • [34] The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension
    Yu Takigami
    Shunsuke Ishii
    Yuko Eda
    Mayu Yazaki
    Teppei Fujita
    Yuichiro Iida
    Yuki Ikeda
    Takeru Nabeta
    Jun Oikawa
    Toshimi Koitabashi
    Junya Ako
    Heart and Vessels, 2023, 38 : 1337 - 1343
  • [35] Unlocking the potential of sacubitril/valsartan therapy in improving ECG and echocardiographic parameters in heart failure patients with reduced ejection fraction (HErEF)
    Lamyaa Elsayed Allam
    Ahmed Aly Abdelmotteleb
    Hayam Mohamed Eldamanhoury
    Hassan Shehata Hassan
    The Egyptian Heart Journal, 76
  • [36] Unlocking the potential of sacubitril/valsartan therapy in improving ECG and echocardiographic parameters in heart failure patients with reduced ejection fraction (HErEF)
    Allam, Lamyaa Elsayed
    Abdelmotteleb, Ahmed Aly
    Eldamanhoury, Hayam Mohamed
    Hassan, Hassan Shehata
    EGYPTIAN HEART JOURNAL, 2024, 76 (01):
  • [37] Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction
    Landolfo, Matteo
    Piani, Federica
    Esposti, Daniela Degli
    Cosentino, Eugenio
    Bacchelli, Stefano
    Dormi, Ada
    Borghi, Claudio
    IJC HEART & VASCULATURE, 2020, 31
  • [38] Long-Term Outcomes of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction and Coexisting End-Stage Renal Disease
    Lin, Wan-Ying
    Shao, Yu-Hsuan Joni
    Chiang, Andy F.
    Huang, Chih-Chieh
    Chiang, Kim F.
    Chan, Chao-Shun
    Huang, Chun-Yao
    Hsiao, Bu-Yuan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (02) : 471 - 477
  • [39] Heart failure with improved ejection fraction (HFimpEF) in patients treated with sacubitril/valsartan (SV)
    Kong, M. G.
    Suh, J.
    Moon, I. K.
    Lee, K. Y.
    Jang, H. J.
    Kim, J. S.
    Choi, I. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 967 - 967
  • [40] Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction
    Passino, Claudio
    Sciarrone, Paolo
    Vergaro, Giuseppe
    Borrelli, Chiara
    Spiesshoefer, Jens
    Gentile, Francesco
    Emdin, Michele
    Giannoni, Alberto
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 112 - 119
12345